Feeds

Brussels acts to ensure arrival of new, unknown legal highs

Crackdown should mean boost for Chinese synthi-drug labs

Beginner's guide to SSL certificates

The European Commission is promising tighter rules on 'legal highs' despite surveys indicating that most people think such action should be based on medical evidence.

Synthetic drugs - the most infamous was labelled meow-meow by the tabloids - mimic the effects of illegal substances like ecstasy and speed. Sold online or through "head shops" as bath salts or plant food they can be entirely synthetic versions of existing drugs or plant-based products, often cathinone, extracted from khat.

The EC said it found 41 new substances available, compared to 24 last year: so the ban is working well. Since 2005 Brussels has recorded 115 substances. In 2009, 24 were logged and in 2008 another 13.

The Commission currently runs an early-warning system for new substances. It said this was working well but was in danger of being overrun by the number of new products hitting the market.

Eurocrats will consider changes to criminal law, new types of monitoring and aligning drug control with food and drink safety measures. It will report back with options to consider in the autumn.

But designer drug-makers, often churning out product from labs based in China, tweak existing drugs in response to slow-moving legislators. For example, labs have moved away from mephedrone since it was banned.

The moves mean that medical staff who are dealing with patients who have taken designer drugs have little or no information on what the likely long or short-term impact of the substance may be. And it leaves drug users with a steep learning curve as they move onto new substances.

Commission research found use of "traditional" drugs was generally stable. Dealers are keener to sell the "legal" highs because they can make just as much cash with no risk of prison.

The rule change coincides with a European-wide survey into attitudes to drugs which found that 5 per cent of teenagers had tried synthetic drugs. In Ireland this rose to 16 per cent against 8 per cent in the UK.

It found just 26.3 per cent of UK teens supported banning such substances without evidence. Altogether 58.3 per cent of UK teens said they should be banned if they were found to damage health.

Tabloid outrage about mephedrone or meow-meow led then Home Secretary Alan Johnson to ban the substance in March 2010.

The Commission noted that 8,500 EC citizens die each year from drug overdoses.

Some details on the new policy for synthetic drugs is here, and the survey results can be downloaded here. ®

Choosing a cloud hosting partner with confidence

More from The Register

next story
BIG FAT Lies: Porky Pies about obesity
What really shortens lives? Reading this sort of crap in the papers
Assange™ slumps back on Ecuador's sofa after detention appeal binned
Swedish court rules there's 'great risk' WikiLeaker will dodge prosecution
You think the CLOUD's insecure? It's BETTER than UK.GOV's DATA CENTRES
We don't even know where some of them ARE – Maude
NSA mass spying reform KILLED by US Senators
Democrats needed just TWO more votes to keep alive bill reining in some surveillance
prev story

Whitepapers

Choosing cloud Backup services
Demystify how you can address your data protection needs in your small- to medium-sized business and select the best online backup service to meet your needs.
Forging a new future with identity relationship management
Learn about ForgeRock's next generation IRM platform and how it is designed to empower CEOS's and enterprises to engage with consumers.
Seattle children’s accelerates Citrix login times by 500% with cross-tier insight
Seattle Children’s is a leading research hospital with a large and growing Citrix XenDesktop deployment. See how they used ExtraHop to accelerate launch times.
5 critical considerations for enterprise cloud backup
Key considerations when evaluating cloud backup solutions to ensure adequate protection security and availability of enterprise data.
High Performance for All
While HPC is not new, it has traditionally been seen as a specialist area – is it now geared up to meet more mainstream requirements?